>
BREAKING: CBS 60 Minutes: revealed a previously unknown weapon that they believe is linked...
The Year of Adam Smith: Why the Savvy Scotsman Remains So Important
Trump sons trigger 'corruption' uproar as Pentagon drone venture surfaces amid Iran war
Will the Dollar be a Casualty of the Iran War?
The Pentagon is looking for the SpaceX of the ocean.
Major milestone by 3D printing an artificial cornea using a specialized "bioink"...
Scientists at Rice University have developed an exciting new two-dimensional carbon material...
Footage recorded by hashtag#Meta's AI smart glasses is sent to offshore contractors...
ELON MUSK: "With something like Neuralink… we effectively become maybe one with the AI."
DARPA Launches New Program Generative Optogenetics, GO,...
Anthropic Outpaces OpenAI Revenue 10X, Pentagon vs. Dario, Agents Rent Humans | #234
Ordering a Tiny House from China, what's the real COST?
New video may offer glimpse of secret F-47 fighter
Donut Lab's Solid-State Battery Charges Fast. But Experts Still Have Questions

Researchers have been left surprised by the effectiveness of an experimental form of this treatment, which involved an injection into one eyeball yet improved vision across both.
Gene therapies have the potential to treat all kinds of health conditions, ranging from cancer, to diabetes in dogs, to obesity and damaged spinal cords. One area where we're seeing some really exciting progress is in hereditary vision loss, with studies demonstrating the potential of gene therapy to treat color blindness, progressive retinal diseases and glaucoma, with some recently receiving approval from the FDA.
Researchers have been left surprised by the effectiveness of an experimental form of this treatment, which involved an injection into one eyeball yet improved vision across both.
Gene therapies have the potential to treat all kinds of health conditions, ranging from cancer, to diabetes in dogs, to obesity and damaged spinal cords. One area where we're seeing some really exciting progress is in hereditary vision loss, with studies demonstrating the potential of gene therapy to treat color blindness, progressive retinal diseases and glaucoma, with some recently receiving approval from the FDA.